Managing Treatment-Resistant Depression
eBook - ePub

Managing Treatment-Resistant Depression

Road to Novel Therapeutics

  1. 612 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Managing Treatment-Resistant Depression

Road to Novel Therapeutics

About this book

Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. - Defines Treatment-Resistant Depression and Staging Treatment Intensity - Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions - Discusses the use of Ketamine and Esketamine for treatment-resistant depression

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Managing Treatment-Resistant Depression by Joao Quevedo,Patricio Riva-Posse,William V. Bobo,Joao L. de Quevedo,Joao Luciano de Quevedo in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Immunology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Academic Press
Year
2022
Print ISBN
9780128240670
eBook ISBN
9780128240687
Topic
Biological Sciences
Subtopic
Immunology
Index
Biological Sciences

Table of contents

  1. Title of Book
  2. Cover image
  3. Title page
  4. Table of Contents
  5. Copyright
  6. Contributors
  7. Chapter 1 Defining treatment-resistant depression, difficult-to-treat depression, and staging treatment intensity
  8. Chapter 2 Clinical and epidemiological predictors of treatment-resistant depression
  9. Chapter 3 The economic burden of treatment-resistant depression: Cost-of-illness perspective
  10. Chapter 4 The neurobiology of treatment-resistant depression
  11. Chapter 5 Modeling treatment-resistant depression in the preclinical setting
  12. Chapter 6 Treatment algorithms for treatment-resistant depression
  13. Chapter 7 Tools to aid precision treatments to prevent or manage treatment-resistant depression (TRD): Pharmacogenomics, machine learning, and artificial intelligence
  14. Chapter 8 Tricyclic antidepressants for treatment-resistant depression
  15. Chapter 9 Monoamine oxidase inhibitors for treatment-resistant depression
  16. Chapter 10 Switching antidepressants in patients with treatment-resistant depression
  17. Chapter 11 Adjunctive strategies for treatment-resistant depression
  18. Chapter 12 Combining antidepressants to address treatment-resistant depression
  19. Chapter 13 Ketamine/esketamine for treatment-resistant depression
  20. Chapter 14 Psychedelic agents for treatment-resistant depression
  21. Chapter 15 Inflammation and treatment resistance: Mechanisms and treatment implications
  22. Chapter 16 Opioid agents for treatment-resistant depression
  23. Chapter 17 Transcranial magnetic stimulation for treatment-resistant depression
  24. Chapter 18 tDCS for treatment-resistant depression
  25. Chapter 19 ECT for treatment-resistant depression
  26. Chapter 20 MST for treatment-resistant depression
  27. Chapter 21 VNS for treatment-resistant depression
  28. Chapter 22 Deep brain stimulation for treatment-resistant depression
  29. Chapter 23 Other neurosurgical interventions for treatment-resistant depression
  30. Chapter 24 Treatment-resistant psychotic depression
  31. Chapter 25 Evidence-based psychotherapy for treatment-resistant depression
  32. Chapter 26 Treatment-resistant bipolar depression
  33. Chapter 27 Treatment-resistant depression in children and adolescents
  34. Chapter 28 Treatment-resistant depression in geriatrics
  35. Chapter 29 Identification and management of anxious depression in patients with treatment-resistant depression
  36. Chapter 30 Managing treatment-resistant depression with comorbid personality disorders
  37. Chapter 31 Managing treatment-resistant depression with comorbid substance use disorders
  38. Chapter 32 Managing treatment-resistant depression in the setting of chronic pain
  39. Chapter 33 Inhaled gases for treatment-resistant major depression
  40. Chapter 34 Drugs under investigation for treatment-resistant depression
  41. Chapter 35 Chronotherapeutics for treatment-resistant depression
  42. Chapter 36 Managing treatment resistant depression in primary care settings
  43. Chapter 37 Treatment-resistant depression in pregnancy, the postpartum period, and transition to menopause
  44. Chapter 38 Lifestyle interventions for treatment-resistant depression
  45. Chapter 39 Managing the risk of suicide in people with treatment-resistant depression
  46. Chapter 40 Maintaining motivation and preserving the therapeutic alliance as tools to overcome treatment-resistant depression
  47. Index